First Trust Small Cap Growth AlphaDEX Fund Rating $83.05 -1.21 (-1.44%) Closing price 03:59 PM EasternExtended Trading$83.20 +0.15 (+0.18%) As of 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsShort InterestTrendsBuy This Stock First Trust Small Cap Growth AlphaDEX Fund Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.FYC Aggregate RatingModerate Buy 2.65Holdings in FYC have an aggregate rating of Moderate Buy based on 192 analyst ratings issued in the past year covering 25 companies (17.5% of the portfolio).FYC Aggregate Price Target$83.05High Prediction$83.05Average Prediction$83.05Low Prediction$83.05Holdings in FYC have an aggregate price target of $83.05 and a range of $83.05 to $83.05 covering 25 companies (17.5% of the portfolio).FYC Consensus Ratings of HoldingsStrong Buy1 Strong Buy rating(s)Buy9 Buy rating(s)Moderate Buy7 Moderate Buy rating(s)Hold7 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell1 Strong Sell rating(s) Ratings for Stocks Held by First Trust Small Cap Growth AlphaDEX Fund Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 FYC Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings0.82%SYMSymbotic$46.80-8.4%2.2507 of 5 stars2.25$42.69 -8.8%200.80%DXPEDXP Enterprises$116.06-4.5%2.5479 of 5 stars3.00$95.00 -18.1%1Insider Trade0.78%SMRNuScale Power$32.67-6.6%2.2897 of 5 stars2.27$34.44 5.4%110.77%LEUCentrus Energy$166.58-6.2%2.6671 of 5 stars2.64$202.09 21.3%140.76%CARAvis Budget Group$156.62-1.3%2.799 of 5 stars2.00$151.50 -3.3%5Insider Trade0.74%EOSEEos Energy Enterprises$6.05-4.4%0.7308 of 5 stars2.33$6.38 5.4%6News CoveragePositive News0.74%LIFLife360$85.60-1.8%1.2151 of 5 stars3.00$86.43 1.0%7Analyst Upgrade0.74%PRMPerimeter Solutions$18.57-0.4%2.6961 of 5 stars3.00$18.50 -0.4%2News CoveragePositive News0.73%WTWisdomTree$13.42-1.8%1.9946 of 5 stars2.57$13.15 -2.0%7Analyst ForecastHigh Trading Volume0.72%TBBKBancorp$65.83+0.6%3.6074 of 5 stars3.00$62.00 -5.8%7News CoveragePositive News0.71%HWKNHawkins$170.81-1.6%3.099 of 5 stars3.00$162.50 -4.9%4Positive NewsShort Interest ↑0.70%POWLPowell Industries$254.10-2.2%3.6048 of 5 stars3.50$312.00 22.8%20.69%RYTMRhythm Pharmaceuticals$97.19-0.9%3.7431 of 5 stars3.07$101.57 4.5%150.68%AGXArgan$214.22-4.9%0.9154 of 5 stars2.25$202.00 -5.7%4Positive News0.67%PBIPitney Bowes$11.42+2.7%3.475 of 5 stars2.001Positive News0.66%ACADACADIA Pharmaceuticals$24.97-0.4%3.9202 of 5 stars2.61$28.88 15.6%18Positive NewsAnalyst Upgrade0.66%TPBTurning Point Brands$96.93-1.7%3.081 of 5 stars3.13$78.83 -18.7%80.66%RSIRush Street Interactive$19.71-1.5%2.7555 of 5 stars2.80$17.89 -9.2%10Analyst Downgrade0.65%UECUranium Energy$9.66-8.9%3.7449 of 5 stars3.33$10.91 12.9%9Positive News0.65%REVGREV Group$51.71-2.2%1.852 of 5 stars2.25$42.25 -18.3%4News CoveragePositive News0.64%PLPlanet Labs PBC$6.39-6.7%1.6186 of 5 stars2.90$6.86 7.4%10Options Volume0.64%GVAGranite Construction$109.45-0.5%0.9079 of 5 stars1.00$76.00 -30.6%1News CoveragePositive News0.64%KAROPENLANE$28.06-1.0%3.5194 of 5 stars2.50$26.50 -5.5%4Positive News0.64%SPRYARS Pharmaceuticals$13.79-1.7%2.6245 of 5 stars3.17$31.00 124.8%6Trending NewsEarnings ReportAnalyst Revision0.64%PTCTPTC Therapeutics$49.59-0.4%4.4493 of 5 stars2.63$70.15 41.5%16Trading HaltedHigh Trading Volume This page (NASDAQ:FYC) was last updated on 8/19/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding First Trust Small Cap Growth AlphaDEX Fund Please log in to your account or sign up in order to add this asset to your watchlist. Share First Trust Small Cap Growth AlphaDEX Fund With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access